COVID Vaccine Supply Limited, Distribution Unclear
Friday, December 11, 2020 (Kaiser News) — High stakes and massive challenges await because the U.S. prepares to roll out vaccines towards COVID-19, with front-line well being care employees and susceptible nursing dwelling residents really helpful as the highest precedence.
Doses may very well be on their method very quickly. An unbiased advisory committee to the Food and Drug Administration on Thursday gave a inexperienced mild to the primary vaccine candidate, made by Pfizer along side the German firm BioNTech — a advice anticipated to be accredited by the company inside days. The committee is scheduled to contemplate a second candidate, made by Moderna, Dec. 17.
On faucet is an preliminary stockpile of vaccines made through the approval course of, with federal officers hoping to distribute a minimum of 20 million doses by yr’s finish.
While that can go a good distance towards reaching the top-priority teams — the nation’s 21 million well being care employees and three million long-term care residents — there received’t be sufficient to inoculate everybody on Day One, and even the primary week.
In Ohio, for instance, the governor expects an preliminary supply of 98,000 doses, with the state allocating 88,000 of these to long-term care services, mentioned Pete Van Runkle, government director of the Ohio Health Care Association, which represents long-term care services.
“It’s more than a drop in the bucket, but it’s not all that’s needed,” mentioned Van Runkle, who estimated there are between 150,000 and 175,000 residents and workers members in long-term care facilities within the state.
Consequently, the doses will probably be distributed in waves, with the facilities and hospitals not chosen for the primary wave getting them within the coming weeks, he mentioned.
Facilities should divvy up the provides to finest tackle the wants of sufferers and staff.
For hospitals, first up are more likely to be “workers with the greatest exposure” to the virus, mentioned Anna Legreid Dopp, a senior director on the American Society of Health-System Pharmacists, a commerce group representing greater than 55,000 pharmacists who work for hospitals and well being techniques.